Oracle is in a difficult position. It already is burning cash, with plans to burn tens of billions more over the next several ...

This recent decline signals renewed worries regarding stagnant cloud profit margins and the risks associated with AI ...

Oracle Corporation is poised for strong AI growth despite debt concerns, with a potential 50% return in 12 months. Learn more ...

SALT LAKE CITY, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates and ...

The general mood among these heavyweight investors is divided, with 40% leaning bullish and 39% bearish. Among these notable options, 37 are puts, totaling $3,134,623, and 116 are calls, amounting to ...

SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Wednesday reported a loss of $162.3 million in its third quarter. The Salt Lake City-based company said it had a ...

Recursion Pharmaceuticals currently has the industry's largest AI supercomputer. It also has partnerships with major drugmakers, but these have yet to yield major wins. Recursion'a lack of clinical ...

The critical pre-authentication RCE flaw is added to CISA’s KEV catalog, with a warning for federal civilian agencies to ...

The cybersecurity agency CISA has confirmed that a recently patched Oracle Identity Manager vulnerability has been exploited in the wild.

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Loomis Sayles, an investment management company, released its “Global Growth Fund” investor letter for the third quarter of ...

Oracle has gone from market darling to cautionary tale in a matter of weeks, with its share price sliding more than 40 ...